Experience
Publications
Read their latest work
Article
FTC pharmacy benefit management transparency report: How might pharma evaluate transparency reform impacts to drug channel stakeholders?
04 September 2024 - by Chad Barker, Chris Page, Matt Berman
In the wake of the FTC’s recent transparency report on pharmacy benefit managers, we look at how reform might impact drug channel stakeholders.
Article
Increasing diversity in clinical trials
27 June 2024 - by Chris Page, Ellyn Russo, Jeremy Engdahl-Johnson
Milliman health researchers discuss strategies and benefits of making sure new medical treatments are tested in patients from a range of backgrounds.